V
Veronica White
Researcher at Barts Health NHS Trust
Publications - 19
Citations - 538
Veronica White is an academic researcher from Barts Health NHS Trust. The author has contributed to research in topics: Tuberculosis & Meropenem. The author has an hindex of 7, co-authored 19 publications receiving 426 citations. Previous affiliations of Veronica White include Royal London Hospital & St Bartholomew's Hospital.
Papers
More filters
Journal ArticleDOI
Effectiveness and safety of bedaquiline-containing regimens in the treatment of MDR- and XDR-TB: a multicentre study
Sergey Borisov,Keertan Dheda,Martin Enwerem,Rodolfo Romero Leyet,Lia D'Ambrosio,Rosella Centis,Giovanni Sotgiu,Simon Tiberi,Simon Tiberi,Jan-Willem C. Alffenaar,Andrey Maryandyshev,Evgeny Belilovski,Shashank Ganatra,Alena Skrahina,Onno W. Akkerman,Alena Aleksa,Rohit Amale,Janina Artsukevich,Judith Bruchfeld,Jose A. Caminero,Isabel Carpena Martinez,Luigi Codecasa,Margareth Pretti Dalcolmo,Justin T Denholm,Paul Douglas,Raquel Duarte,Aliasgar Esmail,Mohammed Fadul,Alexey Filippov,Lina Davies Forsman,Mina Gaga,Julia Amaranta Garcia-Fuertes,José-María García-García,Gina Gualano,Jerker Jonsson,Heinke Kunst,Jillian S.Y. Lau,Barbara Lazaro Mastrapa,Jorge Lazaro Teran Troya,Selene Manga,Katerina Manika,Pablo González Montaner,Jai B Mullerpattan,Suzette Oelofse,Martina Ortelli,Domingo Palmero,Fabrizio Palmieri,Antonella Papalia,Apostolos Papavasileiou,Marie-Christine Payen,Emanuele Pontali,Carlos Robalo Cordeiro,Laura Saderi,Tsetan Dorji Sadutshang,Tatsiana Sanukevich,Varvara Solodovnikova,Antonio Spanevello,Sonam Topgyal,Federica Toscanini,Adrian R Tramontana,Zarir F Udwadia,Pietro Viggiani,Veronica White,Alimuddin Zumla,Giovanni Battista Migliori +64 more
TL;DR: Bedaquiline-containing regimens achieved high conversion and success rates under different nonexperimental conditions, and is safe and effective in treating MDR- and XDR-TB patients.
Journal ArticleDOI
Effectiveness and safety of meropenem/clavulanate-containing regimens in the treatment of MDR- and XDR-TB.
Simon Tiberi,Marie-Christine Payen,Giovanni Sotgiu,Lia D'Ambrosio,Valentina Alarcon Guizado,Jan-Willem C. Alffenaar,Marcos Abdo Arbex,Jose A. Caminero,Rosella Centis,Saverio De Lorenzo,Mina Gaga,Gina Gualano,Aurora Jazmín Roby Arias,Anna Scardigli,Alena Skrahina,Ivan Solovic,Giorgia Sulis,Marina Tadolini,Onno W. Akkerman,Edith Alarcon Arrascue,Alena Aleska,Vera Avchinko,Eduardo Henrique Bonini,Felix Antonio Chong Marin,Lorena Collahuazo López,Gerard de Vries,Simone Dore,Heinke Kunst,Alberto Matteelli,Charalampos Moschos,Fabrizio Palmieri,Apostolos Papavasileiou,Antonio Spanevello,Dante Vargas Vasquez,Pietro Viggiani,Veronica White,Alimuddin Zumla,Giovanni Battista Migliori +37 more
TL;DR: The nondifferent outcomes and bacteriological conversion rate observed in cases who were more severe than controls might imply that meropenem/clavulanate could be active in treating MDR- and XDR-TB cases.
Journal ArticleDOI
Comparison of effectiveness and safety of imipenem/clavulanate- versus meropenem/clavulanate-containing regimens in the treatment of MDR- and XDR-TB
Simon Tiberi,Giovanni Sotgiu,Lia D'Ambrosio,Rosella Centis,Marcos Abdo Arbex,Edith Alarcon Arrascue,Jan-Willem C. Alffenaar,Jose A. Caminero,Mina Gaga,Gina Gualano,Alena Skrahina,Ivan Solovic,Giorgia Sulis,Marina Tadolini,Valentina Alarcon Guizado,Saverio De Lorenzo,Aurora Jazmín Roby Arias,Anna Scardigli,Onno W. Akkerman,Alena Aleksa,Janina Artsukevich,Vera Auchynka,Eduardo Henrique Bonini,Felix Antonio Chong Marin,Lorena Collahuazo López,Gerard de Vries,Simone Dore,Heinke Kunst,Alberto Matteelli,Charalampos Moschos,Fabrizio Palmieri,Apostolos Papavasileiou,Marie-Christine Payen,Andrea Piana,Antonio Spanevello,Dante Vargas Vasquez,Pietro Viggiani,Veronica White,Alimuddin Zumla,Giovanni Battista Migliori +39 more
TL;DR: It is suggested that meropenem/clavulanate is more effective than imipenem/ clavULanate in treating MDR/XDR-TB patients and safe and more effective in treating non-drug-resistant tuberculosis patients.
Journal ArticleDOI
Contact tracing and population screening for tuberculosis – who should be assessed?
TL;DR: This study demonstrates that, in this population, the contact-tracing strategy is more effective than new entrant screening, and is not likely that the contacts have caught their disease from the index case, but rather that in high-incidence areas such as the authors' such tracing selects extended families or communities at particularly high risk.
Journal ArticleDOI
Effectiveness and Safety of Imipenem-Clavulanate Added to an Optimized Background Regimen (OBR) Versus OBR Control Regimens in the Treatment of Multidrug-Resistant and Extensively Drug-Resistant Tuberculosis
Simon Tiberi,Giovanni Sotgiu,Lia D'Ambrosio,Rosella Centis,Marcos Abdo Arbex,Edith Alarcon Arrascue,Jan-Willem C. Alffenaar,Jose A. Caminero,Mina Gaga,Gina Gualano,Alena Skrahina,Ivan Solovic,Giorgia Sulis,Marina Tadolini,Valentina Alarcon Guizado,Saverio De Lorenzo,Aurora Jazmín Roby Arias,Anna Scardigli,Onno W. Akkerman,Alena Aleksa,Janina Artsukevich,Vera Avchinko,Eduardo Henrique Bonini,Felix Antonio Chong Marin,Lorena Collahuazo López,Gerard de Vries,Simone Dore,Heinke Kunst,Alberto Matteelli,Charalampos Moschos,Fabrizio Palmieri,Apostolos Papavasileiou,Marie-Christine Payen,Andrea Piana,Antonio Spanevello,Dante Vargas Vasquez,Pietro Viggiani,Veronica White,Alimuddin Zumla,Giovanni Battista Migliori +39 more
TL;DR: Simone Dore, Heinke Kunst, Alberto Matteelli, Charalampos Moschos, Fabrizio Palmieri, Apostolos Papavasileiou, Marie-Christine Payen, Andrea Piana, Antonio Spanevello, Dante Vargas Vasquez, Pietro Viggiani, Veronica White, Alimuddin Zumla and Giovanni Battista Migliori.